James Rolke

CIK: 0001693858

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)4 (66.7%)

Compensation grants

Other (G, F, J, C, D, …)2 (33.3%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

REVB

REVELATION BIOSCIENCES, INC.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (6 total)

REVB
REVELATION BIOSCIENCES, INC.
Aug 17, 2026
Award(A)
Direct
208.1K shares-
REVB
REVELATION BIOSCIENCES, INC.
Apr 30, 2026
Tax Payment(F)
Direct
10.1K shares at avg. $1.13$11K
REVB
REVELATION BIOSCIENCES, INC.
Feb 3, 2026
Tax Payment(F)
Direct
8.5K shares at avg. $1.86$16K
REVB
REVELATION BIOSCIENCES, INC.
Jan 8, 2026
Award(A)
Direct
532.8K shares at avg. $0.90$480K
REVB
REVELATION BIOSCIENCES, INC.
Oct 29, 2025
Award(A)
Direct
390.6K shares at avg. $1.28$500K
REVB
REVELATION BIOSCIENCES, INC.
Feb 11, 2025
Award(A)
Direct
30.1K shares at avg. $3.87$116K

		Type	Shares	Price		Ownership
Aug 17, 2026	REVB REVELATION BIOSCIENCES, INC.	Award(A)	208,076	-	$0	Direct
Apr 30, 2026	REVB REVELATION BIOSCIENCES, INC.	Tax Payment(F)	10,115	$1.13	$11,430	Direct
Feb 3, 2026	REVB REVELATION BIOSCIENCES, INC.	Tax Payment(F)	8,521	$1.86	$15,849	Direct
Jan 8, 2026	REVB REVELATION BIOSCIENCES, INC.	Award(A)	532,829	$0.90	$479,546	Direct
Oct 29, 2025	REVB REVELATION BIOSCIENCES, INC.	Award(A)	390,614	$1.28	$499,986	Direct
Feb 11, 2025	REVB REVELATION BIOSCIENCES, INC.	Award(A)	30,095	$3.87	$116,468	Direct

1-6 of 6 transactions

About Rolke James

Rolke James (SEC CIK 0001693858) files insider reports with the SEC as Chief Executive Officer of REVELATION BIOSCIENCES, INC. (REVB).

Signal8 holds 6 ownership filings by Rolke James, all Form 4s, filed between Feb 13, 2025 and Aug 18, 2026. Those filings report 6 transactions, from Feb 11, 2025 to Aug 17, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Rolke James's filings is in SAN DIEGO, CA.

Recent filings by Rolke James

Aug 17, 2026: Grant or award of REVB shares (Form 4, code A).
Apr 30, 2026: Tax withholding of REVB shares (Form 4, code F).
Feb 3, 2026: Tax withholding of REVB shares (Form 4, code F).
Jan 8, 2026: Grant or award of REVB shares (Form 4, code A).
Oct 29, 2025: Grant or award of REVB shares (Form 4, code A).

Other insiders filing for REVELATION BIOSCIENCES, INC. (REVB)

Chawla Lakhmir S, Director
Zygmont Chester Stanley III, Chief Financial Officer
ROPER JESS, Director
CARVER JENNIFER, Director
TIDMARSH GEORGE F, Director

How to read Form 4 transaction codes